Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Deutsches Arzteblatt International|July 12, 2021
N-Nitrosodimethylamine-Contaminated Valsartan and the Risk of Cancer—A Longitudinal Cohort Study Based on German Health Insurance DataWilly Gomm, Christoph Röthlein, Katrin Schüssel, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims DataWilly Gomm, Klaus von Holt, Friederike Thomé, et al.
European Journal of Neurology|March 26, 2026
Fluoroquinolone-Associated Peripheral and Central Nervous System-Related Disorders: A Large German Claims-Based Cohort StudyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
International Journal of Molecular Sciences|April 12, 2022
Cav3 T-Type Voltage-Gated Ca2+ Channels and the Amyloidogenic Environment: Pathophysiology and Implications on Pharmacotherapy and PharmacovigilanceAnna Papazoglou, Muhammad Imran Arshaad, Christina Henseler, et al.
Pharmacotherapy|April 26, 2025
Fluoroquinolones and the risk of aortic aneurysm or dissection: A population-based propensity score-matched German cohort studyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
Journal of the American Geriatrics Society|March 23, 2018
Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance DataHeidi Taipale, Willy Gomm, Karl Broich, et al.
BMC Ophthalmology|August 7, 2025
Association between fluoroquinolones and retinal detachment: insights from a large German health claims-based cohort studyJulia Wicherski, Jonas Peltner, Cornelia Becker, et al.
Bioorganic & Medicinal Chemistry|March 1, 2011
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)Anne Pick, Henrik Müller, Ralf Mayer, et al.
Pageof 7